Format

Send to

Choose Destination
Int J Cardiol. 2016 Jul 15;215:201-8. doi: 10.1016/j.ijcard.2016.04.077. Epub 2016 Apr 17.

Impact of morphine on antiplatelet effects of oral P2Y12 receptor inhibitors.

Author information

1
Department of Cardiology and Internal Medicine, Collegium Medicum, Nicolaus Copernicus University, Bydgoszcz, Poland.
2
Department of Health Promotion, Collegium Medicum, Nicolaus Copernicus University, Bydgoszcz, Poland.
3
Department of Clinical Pharmacology, Medical University of Vienna, Vienna, Austria.
4
Department of Principles of Clinical Medicine, Collegium Medicum, Nicolaus Copernicus University, Bydgoszcz, Poland. Electronic address: piotr.adamski@wp.eu.
5
Department of Internal Medicine, Division of Cardiology, Pulmonology and Vascular Medicine, Heinrich-Heine-University, Düsseldorf, Germany.
6
Department of Cardiology, Medical University of Vienna, Vienna, Austria.
7
Department of Theoretical Foundations of Biomedical Science and Medical Informatics, Collegium Medicum, Nicolaus Copernicus University, Bydgoszcz, Poland.
8
Department of Principles of Clinical Medicine, Collegium Medicum, Nicolaus Copernicus University, Bydgoszcz, Poland.
9
Inova Center for Thrombosis Research and Drug Development, Inova Heart and Vascular Institute, Fairfax, VA, USA.

KEYWORDS:

Clopidogrel; Drug–drug interaction; Morphine; Prasugrel; Ticagrelor

PMID:
27128531
DOI:
10.1016/j.ijcard.2016.04.077
[Indexed for MEDLINE]
Free full text

Supplemental Content

Full text links

Icon for Elsevier Science
Loading ...
Support Center